Results

Total Results: 1,430 records

Showing results for "continued".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
    October 01, 2016 - Conclusions with strength of evidence for an effect or lack of effect (continued) 14 Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued) 15 Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued) 16 Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued) 17 Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued) aFigures represent
  2. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - Long term observational extension studies from these RCTs show that patients who continued on pharmaceutical … less, since in the one RCT of urate lowering therapy where prophylactic colchicine or NSAIDs were continued … Summary of prior knowledge, findings from the systematic review, and strength of evidence, by KQ (continued … Summary of prior knowledge, findings from the systematic review, and strength of evidence, by KQ (continued … Summary of prior knowledge, findings from the systematic review, and strength of evidence, by KQ (continued
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
    January 01, 2010 - With continued administration, it is expected that the treatment regimen will make the patient tolerant … immunotherapy, recognized its potential as a viable alternative to subcutaneous therapy, and encouraged continued … Long-term outcomes a) Evidence for sustained clinical benefit with continued treatment (maintenance … capability of SIT to result in remission of the disease entity itself; this may be manifest as an effect of continued … Maintenance control: capability of SIT to provide sustained clinical benefit with continued use.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
    July 14, 2016 - Response Results Phyllis Foxworth (Depression and Bipolar Support Alliance) Key Questions [continued … General Phyllis Foxworth (Depression and Bipolar Support Alliance) Recommendations [continued] … Response General Phyllis Foxworth (Depression and Bipolar Support Alliance) Recommendations [continued
  5. Cover Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
    September 01, 2007 - Leadership: Continued leadership is necessary to maintain and manage an incident reporting system and … Critical Success Factors 5.1 Factors Influencing Pharmacy Participation The successful adoption and continued … hypothesize that while organizational buy-in is necessary for initial adoption of a new system, its continued
  6. Cover Page (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
    September 01, 2007 - Leadership: Continued leadership is necessary to maintain and manage an incident reporting system and … Critical Success Factors 5.1 Factors Influencing Pharmacy Participation The successful adoption and continued … hypothesize that while organizational buy-in is necessary for initial adoption of a new system, its continued
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
    December 01, 2015 - Inclusion/exclusion criteria (continued) Criteria Inclusion Exclusion Interventions (continued) Other … Inclusion/exclusion criteria (continued) Criteria Inclusion Exclusion Outcomes • Benefits: response
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - First generation antipsychotics included in the CER (continued) Generic name Trade names(s) Mode of … First generation antipsychotics: FDA status (continued) Drug FDA status Indications Age group approved … Second generation antipsychotics: FDA status (continued) Drug FDA status (year approved) Indications
  9. effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
    May 29, 2025 - Using Collaborative Platforms for Communities of Practice INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE SPEAKER: LAKSHMI GRAMA, SENIOR DIGITAL CONTENT STRATEGIST, NATIONAL CANCER INSTITUTE (NCI) GRAMA: I’m Lakshmi Grama from the Office of Communications and Education at the National …
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
    April 01, 2012 - AHRQ Comparative Effectiveness Review Surveillance Program CER #32: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults Original release date: August 8, 2011 Surveillance Report: July, 2012 Key Findings: - The conclusions for KQ2 (phased testing), KQ3 (preoperative screening), KQ6 (compliance…
  11. effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
    April 01, 2006 - Instead, the reporting is sensationalized: Sensationalism continued… The journalist overstates a
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
    January 01, 2013 - This encouraged continued discussion and open-ended responses to polling questions. 16 The
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
    July 01, 2016 - Overview of Clinical Research Evidence (Continued) Table 2: Adverse Effects Associated With Interventions
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
    January 01, 2024 - Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events Evidence-based Practice Center Systematic Review Protocol Project Title: Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events I. Background and Purpose of the Systematic Review Background The fatt…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
    February 01, 2017 - of EBRT and no extra toxicity.17 Bisphosphonates and EBRT The updated literature review highlights continued
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
    August 09, 2012 - Finally, we thank Mark Helfand, M.D., M.P.H., for his insights and continued support. … Both the systematic review and the Conference revealed that VBAC rates continued to decline despite … Phase 2, Delphi round 1: detailed responses (continued) Question a High (%) (n) Medium (%) (n) … Phase 2, Delphi round 1: detailed responses (continued) Question a High (%) (n) Medium (%) (n) … Future research agenda for vaginal birth after cesarean (continued) Ranked Priority Research Area
  17. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - In this example, continued exposure improves the effectiveness of the intervention, but when the intervention … Continued exposure to oral corticosteroids may continue to increase the risk of fracture associated
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
    October 01, 2012 - Improving Health Care and Palliative Care for Advanced and Serious Illness Disposition of Comments Report Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1303 Published Online: October 2012. Comparative Effectiveness Research Review Dis…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
    September 01, 2011 - Ananth et al6, in viewing over 17 million births from 1990-99 found that while deliveries <37 weeks continued … Peer Reviewer 2 Discussion/ Conclusion I would like to see a comment added that its continued use should
  20. effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
    October 01, 2021 - Continued on page 2 2 Background and Purpose Breast cancer is the most common new cancer diagnosis

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: